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ABSTRACT 37 
If a bone or joint infection is suspected, perioperative antibiotic prophylaxis is frequently 38 
withheld until the intraoperative microbiological sampling has been performed. This 39 
practice builds upon the hypothesis that perioperative antibiotics could render culture 40 
results negative and thus impede tailored antibiotic treatment of infections. We aimed to 41 
assess the influence of antibiotic prophylaxis within 30 to 60 minutes before surgery on 42 
time to positivity of microbiological samples and proportion of positive samples in 43 
Cutibacterium acnes bone and joint infections. Patients with at least one positive C. 44 
acnes sample between January 2005 and December 2015 were included and classified 45 
as ‘infection’ if at least 2 samples were positive, otherwise they were considered a 46 
‘contamination’. Kaplan-Meier curves were used to illustrate time to culture positivity. 47 
We found 64 cases with a C. acnes infection and 46 classified as a C. acnes 48 
contamination.Application of perioperative prophylaxis significantly differed between the 49 
‘infection’ and ‘contamination’ group (72.8% versus 55.8%, p<0.001). Within the 50 
‘infection’ group, we found no difference in time to positivity between those who had or 51 
had not received a perioperative prophylaxis (7.07 days (95% CI 6.4-7.7) vs. 7.11 days 52 
(95% CI 6.8-7.5), p=0.3). Also, there was no association between the proportion of 53 
sample positivity and the application of perioperative prophylaxis (71.6% versus 65.9%, 54 
p=0.39). Since perioperative prophylaxis did not negatively influence the microbiological 55 
yield in C. acnes infections, routine antibiotic prophylaxis can be routinely given to avoid 56 
surgical site infections.  57 
 58 
 59 
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INTRODUCTION 60 
In orthopedic surgery, antimicrobial prophylaxis is routinely given to reduce the risk for 61 
surgical site infections and colonization of implanted orthopedic devices (1, 2). It is 62 
recommended to give an antibiotic agent with bactericidal effect within a window of 30 63 
to 60 minutes prior to skin incision in order to target skin commensal bacteria, such as 64 
staphylococci, streptococci, or cutibacteria (2). Despite correctly applied antibiotic 65 
prophylaxis, orthopedic bone and joint infections still occur in about 1-10% of cases (3). 66 
These orthopedic bone and joint infections are typically caused by microorganisms 67 
growing in biofilms. Usually, these biofilms are heterogeneously distributed, which is 68 
challenging for an accurate localization of infection for diagnostic sampling (4). Biofilm 69 
microorganisms are in a metabolically inactive, non-replicating state which make them 70 
tolerant to our immune system and to antibiotics (5). Furthermore, biofilm bacteria are 71 
enclosed in a polymeric matrix, which protects them from antimicrobial agents and 72 
immune responses; biofilm bacteria are therefore difficult to reach, extract and cultivate 73 
(4, 6). All of these factors contribute to the challenge of diagnosing biofilm infections 74 
including bones and joint infections. Due to these difficulties, when a bone or joint 75 
infection is suspected, and surgical treatment is necessary, application of perioperative 76 
antibiotic prophylaxis is oftentimes withheld with the goal of increasing the 77 
microbiological yield of positive intraoperative biopsy cultures to identify the pathogen 78 
(7-10). Only knowing the causative microorganism of the infection allows a correct 79 
tailored longterm antimicrobial treatment  80 
 However, recent studies (11-15) have shown that exposure to antibiotic agents 81 
as perioperative single-shot prophylaxis ahead of the intraoperative microbiological 82 
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sampling is not associated with an increase in culture-negative results. Furthermore, 83 
studies claim that perioperative antibiotic prophylaxis is needed in septic orthopedic 84 
surgeries since it significantly reduces infection rates (16-18). However, these studies 85 
were of small sample size, and the heterogeneity of the infections including both virulent 86 
and low-virulent pathogens are major concerns.  87 
C. acnes is a slow growing pathogen, which is often involved in bone and joint 88 
infections (19) and is therefore qualified for studying the effect of preoperative antibiotic 89 
prophylaxis in orthopedic settings. Since previous studies primarily assessed the 90 
influence of preoperative prophylaxis on intraoperative culture results, studies 91 
examining the number of positive samples and the time to positivity or confirmation of 92 
the infection are lacking.  93 
 This study builds upon prior results from a large and homogenous cohort of 94 
patients with suspected C. acnes bone and joint infections (6). We aimed to assess the 95 
effect of preoperative antibiotic prophylaxis on time to positivity of C. acnes samples, 96 
which is a crucial factor for the physician with regard to further therapeutic 97 
management. Furthermore, we evaluated the number of positive samples and the time 98 
to confirmation of a C. acnes infection in patients with and without perioperative 99 
antibiotic prophylaxis.  100 
 101 
METHODS 102 
Study population 103 
We retrospectively included patients from the University Hospital Balgrist in Zurich with 104 
at least one positive intraoperative sample for C. acnes, isolated between January 2005 105 
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and December 2015. We excluded patients with no available data on antibiotic 106 
prophylaxis at the time of surgery. Since antibiotic treatment might influence the time to 107 
positivity of C. acnes growth, we also excluded samples from patients who had taken 108 
antibiotics for ≥24 h within 14 days prior to sample acquisition. The University Hospital 109 
Balgrist in Zurich, Switzerland, is an orthopedic clinic specialized in bone and joint 110 
infections. Approximately 5000 surgical procedures are annually performed.  111 
For clinical and demographic parameters at the time of diagnostic work-up, the patient 112 
clinical database of the orthopedic clinic and the prospective database of the infectious 113 
diseases consultation service were accessed. Microbiological data were collected using 114 
the database of the Institute of medical microbiology, University of Zurich, Zurich, 115 
Switzerland.  116 
Within the same patient, same hospitalization period, same surgery and same 117 
infection site, all samples were clustered as one diagnostic set per patient case, 118 
regardless if the sample came back positive or negative. Patients were grouped into the 119 
following two groups: ‘infection’ group if C. acnes was detected in at least two different 120 
samples within the same patient case and ‘contamination’ group if there was only one 121 
positive sample with C. acnes. In order to ensure an accurate allocation to one of the 122 
two groups, only cases with three or more analyzable samples were included in this 123 
analysis (10, 20).  124 
The study was approved by the institutional review board in Zurich, Switzerland 125 
(KEK Zurich number 2016-00145).  126 
 127 
Analysis and statistical methods 128 
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For each sample of a patient diagnostic set, we collected details about the diagnostic 129 
method used for detection of C. acnes, such as tissue or bone samples, sonication fluid, 130 
synovial fluid or wound swab, and Gram staining.  131 
 We calculated time to positivity of C. acnes growth for each positive sample as 132 
difference in days between start of microbiological culture and identification of C. acnes.  133 
Among the ‘infection’ group, time to positivity was referring to culture positivity of the 134 
second positive sample to confirm the infection and account for possible contamination.  135 
 We analyzed the proportion of positive microbiological samples (ratio of positive 136 
samples to the total of all samples taken for each patient) in order to account for the 137 
larger number of samples taken if an infection was suspected during surgery. We 138 
performed a sensitivity analysis to assess potential associations and systematic 139 
distortion of the results by the larger number of samples per patient required to be 140 
classified into the ‘infection’ group. We therefore conducted a Cox proportional hazards 141 
regression with robust standard errors, adjusted for the number of samples taken and 142 
allowing for clustering of samples within patients. 143 
Statistical analysis was performed using Stata 15.0 SE (StataCorp, College 144 
Station, TX). We used parametric (Student’s t-test) and non-parametric tests (Wilcoxon 145 
rank-sum test for continuous variables, Fisher’s exact test for categorical variables) to 146 
compare variables both on a patient or on a sample level, whichever seemed 147 
appropriate.  148 
We used Kaplan-Meier curves to illustrate the number of days from the 149 
intraoperative sampling to culture positivity both the ‘infection’ and ‘contamination’ 150 
 o
n
 D
ecem
ber 4, 2017 by UZH Hauptbibliothek / Zentralbibliothek Zuerich
http://jcm.asm.org/
D
ow
nloaded from
 
 Anagnostopoulos - JCM submission 
8 
 
group. Differences between the times to positivity of both groups were analyzed by 151 
using log-rank tests. 152 
 153 
Microbiological processing 154 
Diagnostic cultures 155 
All the applied preanalytic and cultivation processes, including the incubation times of 156 
10 days, have been previously described in detail (6). Tissue samples were vortexed, 157 
homogenized, and incubated on agar plates and thioglycolate broth, yet, bone samples 158 
were inoculated in thioglycolate broth only. Explanted hardware was sonicated, and 159 
cultivated on agar based media and thioglycolate, as recently published (6). For the 160 
sonication samples, a threshold of 50 colony-forming units (CFU)/ml bacteria on agar 161 
plates was considered positive. 162 
 163 
Time to positivity of C. acnes growth 164 
As previously described (6), time to positivity was defined as the time (in days) between 165 
the start of microbiological culture and one of the following: 1) C. acnes - typical 166 
colonies on agar plates, 2) turbidity in thioglycolate broth, or 3) a positive signal in blood 167 
culture bottles for which C. acnes was subsequently identified on agar plates.  168 
 169 
RESULTS 170 
Clinical data and perioperative antibiotic prophylaxis 171 
Patient level 172 
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A total of 110 patients, predominantly male (69.1%) and with a median age of 58.5 173 
years (interquartile range (IQR) 50-68) contributed to overall 550 intraoperative 174 
samples, collected between January 2005 and December 2015. Among the most 175 
common sample sites were shoulder (N = 72) and hip (N = 25), followed by knee (N = 176 
6). In 87.3% patients, a prosthesis (58/110) or another foreign body (38/110) was 177 
present. In 64 patients (58.2%), an infection with C. acnes was diagnosed, defined as at 178 
least two positive samples, while identification of C. acnes in only one sample of the 179 
remaining 46 patients (41.8%) did not fulfill the criteria of a proven infection and was 180 
therefore considered contamination.  181 
We analyzed 550 samples, of these 484 (88%) were tissue biopsies (including 182 
wound swabs and fluids), 54 (9.8%) sonication fluid from removed implants, and 12 183 
(2.2%) bone biopsies. This distribution did not significantly differ between the ‘infection’ 184 
group and the ‘contamination’ group (p=0.49). The mean number of samples taken per 185 
patient were 5.3 in the ‘infection’ group (IQR 4-8) and 4.5 in the ‘contamination’ group 186 
(IQR 3-6). In the ‘infection’ group, a median of three samples (IQR 2-5) were positive 187 
with C. acnes. Patient characteristics and sample specifications are shown in Table 1. 188 
Out of the 64 patients in the ‘infection’ group, 44 (68.8%) had not received 189 
perioperative prophylaxis until intraoperative biopsies for microbiology had been taken, 190 
compared to only 23 (50%) in the ‘contamination’ group (p=0.047). If antibiotic 191 
prophylaxis had been applied, it was mostly cefuroxime (83.7%), followed by cefazolin 192 
(9.3%) (Table 1). Distribution of infection and antibiotic prophylaxis status on a patient 193 
and sample level are illustrated in Fig. 1.  194 
 195 
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Time to sample positivity 196 
A total of 274 out of 550 (49.8%) analyzed samples detected C. acnes. Among those, 197 
the mean time to culture positivity as defined for each group was significantly shorter in 198 
the 228 samples of the ‘infection’ group (6.04 days, 95% CI 5.71-6.37) as compared to 199 
the 46 samples of the ‘contamination’ group (8.37 days, 95% CI 7.69-9.05, p<0.001) 200 
(Fig. 2a). 201 
In order to investigate the influence of perioperative prophylaxis on cultivation 202 
time of C. acnes within a comparable group of patients, we assessed the time to sample 203 
positivity in the ‘infection’ group only. Of all 342 samples of the 64 patients in the 204 
‘infection’ group, 72.8% (249/342) were collected in patients who had not been exposed 205 
to perioperative prophylaxis as compared to the low percentage of 27.2% (93/342) with 206 
prophylaxis exposure (Fig. 1). However, the time to positivity within the ‘infection’ group 207 
did not significantly differ between those samples collected from patients exposed to 208 
perioperative prophylaxis (mean 7.07, 95% CI 6.4-7.7) and those not exposed to 209 
perioperative prophylaxis (mean 7.11, 95% CI 6.8-7.5) (p=0.3) (Fig. 2b). The sensitivity 210 
analysis confirmed that this finding was not affected by the total number of samples 211 
taken per patient (adjusted Hazard Ratio 0.84 (0.60-1.18), p=0.31).  212 
 213 
Proportion of sample positivity 214 
Perioperative antibiotic prophylaxis could also have an influence on the number of 215 
positive samples within a case. Overall, the proportion of sample positivity among all 216 
110 patients (‘infection’ and ‘contamination’ group combined) was 50.9% (95% CI 45.4-217 
56.5). In the 67/110 patients (60.9%), in which no perioperative prophylaxis had been 218 
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applied, the proportion of sample positivity was 54.5% (95% CI 46.8-62.1), while the 219 
remaining 43 patients (39.1%) with perioperative prophylaxis had a proportion of sample 220 
positivity of 45.5%. There was no significant difference in the proportion of sample 221 
positivity between the patients with and without perioperative prophylaxis (p=0.12).  222 
Among the 64 patients with a proven C. acnes infection, the proportion of sample 223 
positivity was 69.8% (95% CI 63.8-75.8). Of these 64 patients, 44 (68.8%) had not 224 
received perioperative prophylaxis; their proportion of sample positivity was 71.6% (95% 225 
CI 64.1-79.1). The remaining 20 patients (31.2%) with perioperative prophylaxis had a 226 
proportion of sample positivity of 65.9% (95% CI 55.3-76.5). Hence, in the ‘infection’ 227 
group only, there was no significant difference in the proportion of sample positivity 228 
between infection patients with perioperative prophylaxis and those without application 229 
of antibiotics before or during surgery (p=0.39).  230 
 231 
DISCUSSION 232 
This is the first study analyzing the influence of perioperative prophylaxis on time to 233 
diagnosis and proportion of positive samples in a homogenous group of bone and joint 234 
infections caused by the same pathogen, C. acnes. As bone and joint infections are 235 
causing significant morbidity for the individual and account for large health care 236 
expenses (21), the combination of surgical interventions and targeted biofilm-active 237 
antibiotic treatment against the causative pathogen is crucial in order to regain 238 
functionality (8). Therefore, the timely microbiological identification is one of the 239 
mainstays in treating orthopedic infections. We showed that administering perioperative 240 
antibiotic prophylaxis did not affect the time to diagnosis of C. acnes infection and 241 
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therefore will not prolong the timely identification of pathogen in bone and joint 242 
infections. Our findings support the routine administration of perioperative prophylaxis, 243 
which has previously shown to significantly lower surgical site infection rates (1, 2, 22). 244 
One systematic review (18) found a relative risk reduction of 81% of developing 245 
postsurgical wound infections among patients with total hip and knee replacements, if 246 
perioperative prophylaxis had been administered correctly. Since hip and knee were 247 
also the most common surgical sites in our population, a risk reduction of wound 248 
infections to this extent would have major implications on the morbidity of our patients 249 
and thus our findings.  250 
 251 
Proportion of positive samples within a diagnostic set in our study population of 252 
C. acnes infections did not differ between patients with and without perioperative 253 
prophylaxis (65.9% versus 68.8%). Bone and joint infections are typically biofilm-254 
associated infections, in which bacteria are protected from antibiotic agents (8). In order 255 
to kill biofilm bacteria in the stationary phase, bactericidal antimicrobial substances (23) 256 
with a good ability to penetrate the biofilm, such as rifampin are required (8). 257 
Cephalosporins, commonly used for perioperative prophylaxis, do not have these 258 
characteristics. Since the application of a preoperative single-shot antibiotic prophylaxis 259 
is primarily active against planktonic bacteria in the bloodstream and tissue, but is 260 
unable to penetrate the biofilm, antibiotic prophylaxis has no effect on culture positivity 261 
of intraoperative microbiological samples (13, 15, 24).  262 
 263 
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We recommend the routine administration of antibiotic prophylaxis, even when an 264 
C. acnes infection is suspected, as the administration of a single shot antibiotic 265 
prophylaxis did not affect the intraoperative diagnostic yield. Our recommendation is in 266 
line with the American Academy of Orthopedic Surgeons (AAOS) guidelines from 2011 267 
(15) as well as with a recently published systematic review (24) assessing the influence 268 
of perioperative prophylaxis on culture yield among patients with prosthetic joint 269 
infections. The authors of both studies (15, 24) did not find a significant difference 270 
between the prophylaxis and the non-prophylaxis group, which would outweigh the risk 271 
of a postoperative infectious complication if perioperative prophylaxis was withheld. The 272 
recommendation of our study, the AAOS guidelines (15), and the systematic review (24) 273 
to routinely apply perioperative prophylaxis is not yet included in the French guidelines 274 
for bone and joint infections (9) nor in the IDSA guidelines (10) from 2013, which 275 
recommend to withhold antimicrobial prophylaxis when the preoperative risk of a 276 
prosthetic joint infection is high based on the results of the history, exams, 277 
sedimentation rate, CRP level, and preoperative aspiration.  278 
 279 
The strength of our study is the large homogenous cohort of 64 cases with a 280 
proven C. acnes bone or joint infection. This is to our knowledge, the largest cohort 281 
study to date that is focusing exclusively on this low-virulent and yet very relevant 282 
pathogen within the orthopedic context. For our study, we did explicitly not choose a 283 
virulent pathogen, such as Staphylococcus aureus, since identification of virulent 284 
pathogens is often less challenging, even if a short course of antibiotic treatment had 285 
been given prior to surgery. A further strength of our study is the novel aspect of our 286 
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analysis, including the comparison of time to positivity between different patient groups 287 
as well as analysis of the proportion of positive samples within the patient clusters.  The 288 
long-running microbiological protocols for all bone and joint samples in our cohort 289 
secured the comparability of the culture results. A limitation of our study is the 290 
retrospective study design, which set certain restrictions in terms of availability of 291 
information and comparison to control groups.  292 
 293 
In conclusion, based on to our results in patients with C. acnes bone and joint 294 
infections, perioperative antibiotic prophylaxis did not influence the intraoperative 295 
diagnostic yield of microbiological cultures. We therefore recommend that perioperative 296 
antibiotic prophylaxis in elective orthopedic infection operations should be routinely 297 
given and not be withheld until all intraoperative biopsies were taken . This will minimize 298 
on the one hand the risk of bacterial infection of the surgical field and on the other hand 299 
this will protect the newly implanted hardware.  300 
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TABLES AND FIGURES 387 
Table 1. Clinical characteristics of 64 patients with bone and joint infections caused by 388 
C. acnes (≥ 2 positive C. acnes samples) and 46 cases with no infection (1 positive C. 389 
acnes sample). 390 
 Overall 
N=110 (%) 
Infection 
N=64 (%) 
No infection 
N=46 (%) 
p value 
Patient characteristics     
Male gender (%) 76 (69.1) 45 (70.3) 31 (67.4) 0.84 
Age [years], median (IQR) 58.5 (50-68) 58.5 (47.5-68) 58.5 (51-69) 0.48 
Sample site    0.06 
Shoulder 72 (65.5) 47 (73.4) 25 (54.4)  
Hip 25 (22.7) 12 (18.8) 13 (28.3)  
Spine 5 (4.6) 4 (6.2) 1 (2.2)  
Knee 6 (5.5) 1 (1.6) 5 (10.9)  
Other 2 (1.7) 0 (0.0) 2 (4.2)  
Sample type    0.38 
Tissue and/or bone 79 (71.8) 48 (75.0%) 31 (67.4%)  
Sonication fluid 32 (28.2) 16 (25.0%) 15 (32.6%)  
Number samples, mean 
(IQR) 
5 (3-6) 5.3 (4-8) 4.5 (3-6) <0.001 
Total positive samples per 
case, median (IQR) 
2 (1-4) 3 (2-5) 1  
Presence of foreign body    0.28 
Prosthesis 58 (52.7) 31 (48.4) 27 (58.7)  
Other foreign body 38 (34.5) 27 (42.2) 11 (23.9)  
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 Overall 
N=110 (%) 
Infection 
N=64 (%) 
No infection 
N=46 (%) 
p value 
Perioperative prophylaxis     
Yes 43 (39.1) 20 (31.2%) 23 (50.0%) 0.05 
Prophylaxis agent    0.14 
Cefuroxime 36 (32.7) 17 (26.6) 19 (41.3)  
Cefazolin 4 (3.6) 2 (3.1) 2 (4.4)  
Clindamycin 2 (1.8) 0 (0.0) 2 (4.4)  
Vancomycin 1 (0.9) 1 (1.6) 0 (0.0)  
 391 
 392 
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Fig. 1. Distribution of infection and preoperative prophylaxis status on a patient and 393 
sample level. 68.8% of the patients in the ‘infection’ group did not receive antibiotic 394 
prophylaxis, compared to 50% of patients in the ‘contamination’ group. 395 
Abbreviations: AB, antibiotic 396 
 397 
 398 
 399 
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Fig. 2a. Kaplan-Meier curve illustrating the proportion of sample positivity with C. acnes 400 
in all 274 positive samples, stratified by infection status (228 in the ‘infection’ group vs. 401 
46 in the ‘contamination’ group). The median time to positivity was 6 days for the 402 
‘infection’ group and 9 days for the ‘contamination’ group (log rank p<0.001). The 403 
colored areas represent the 95% confidence interval. 404 
 405 
 406 
  407 
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Fig. 2b. Kaplan-Meier curve illustrating the proportion of sample positivity with C. acnes 408 
in the 342 samples of the ‘infection’ group, stratified by preoperative prophylaxis (93 in 409 
the ‘prophylaxis’ group vs. 249 in the ‘no prophylaxis’ group). The median time to 410 
positivity was 8 days for the ‘prophylaxis’ group and 7 days for the ‘no prophylaxis’ 411 
group (log rank p=0.3). The colored areas represent the 95% confidence interval. 412 
 413 
  414 
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FIGURE LEGENDS 415 
Fig. 1. Distribution of infection and preoperative prophylaxis status on a patient and 416 
sample level. 68.8% of the patients in the ‘infection’ group did not receive antibiotic 417 
prophylaxis, compared to 50% of patients in the ‘contamination’ group. 418 
Abbreviations: AB, antibiotic 419 
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